Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …

Background Aspirin is a cornerstone of preventive treatment for stroke recurrence, but during
the last few years the role of dual antiplatelet therapy (DAPT) is much more emerging …

Background: Evidence about the use of dual antiplatelet therapy (DAPT) with aspirin and
P2Y12 inhibitors in patients with acute minor ischemic stroke or transient ischemic attack …

Background Dual antiplatelet therapy (DAPT) with clopidogrel plus aspirin is a well-
established practice after a minor stroke or transient ischemic attack (TIA). However …

Importance Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin is effective in
preventing recurrent strokes after minor ischemic stroke or transient ischemic attack (TIA) …

Background Recent clinical trials established the benefit of dual antiplatelet therapy with
aspirin and clopidogrel (DAPT‐AC) in early‐presenting patients with minor ischemic stroke …

Background and Purpose: Antiplatelet therapy is key for preventing thrombotic events after
transient ischemic attack or ischemic stroke. Although the role of aspirin is well established …

The efficacy of early administration of dual antiplatelet therapy (DAPT) for secondary
prevention after acute ischemic stroke or transient ischemic attack (TIA) is uncertain. This …

Background and purpose Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for
90 days was recommended as the secondary prevention of minor ischaemic strokes or …

Background: This study compared the effectiveness of dual antiplatelet therapy (DAPT) with
clopidogrel-aspirin with that of aspirin monotherapy (AM) in mild-to-moderate acute ischemic …